This company listing is no longer active
R1 RCM Past Earnings Performance
Past criteria checks 0/6
R1 RCM has been growing earnings at an average annual rate of 11.1%, while the Healthcare industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 16.9% per year.
Key information
11.1%
Earnings growth rate
18.8%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 16.9% |
| Return on equity | -2.2% |
| Net Margin | -2.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How R1 RCM makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,464 | -61 | 241 | 0 |
| 30 Jun 24 | 2,380 | -40 | 233 | 0 |
| 31 Mar 24 | 2,313 | -33 | 237 | 0 |
| 31 Dec 23 | 2,254 | 3 | 220 | 0 |
| 30 Sep 23 | 2,212 | -35 | 219 | 0 |
| 30 Jun 23 | 2,135 | -65 | 222 | 0 |
| 31 Mar 23 | 1,966 | -91 | 190 | 0 |
| 31 Dec 22 | 1,806 | -63 | 173 | 0 |
| 30 Sep 22 | 1,672 | -1 | 152 | 0 |
| 30 Jun 22 | 1,556 | 45 | 127 | 0 |
| 31 Mar 22 | 1,518 | 91 | 126 | 0 |
| 31 Dec 21 | 1,475 | -505 | 122 | 0 |
| 30 Sep 21 | 1,404 | -495 | 116 | 0 |
| 30 Jun 21 | 1,332 | -512 | 108 | 0 |
| 31 Mar 21 | 1,293 | -526 | 103 | 0 |
| 31 Dec 20 | 1,270 | 47 | 101 | 0 |
| 30 Sep 20 | 1,256 | 14 | 102 | 0 |
| 30 Jun 20 | 1,250 | 16 | 105 | 0 |
| 31 Mar 20 | 1,231 | 3 | 108 | 0 |
| 31 Dec 19 | 1,186 | -9 | 105 | 0 |
| 30 Sep 19 | 1,135 | -22 | 106 | 0 |
| 30 Jun 19 | 1,084 | -42 | 107 | 0 |
| 31 Mar 19 | 997 | -41 | 104 | 0 |
| 31 Dec 18 | 869 | -64 | 98 | 0 |
| 30 Sep 18 | 746 | -99 | 84 | 0 |
| 30 Jun 18 | 619 | -88 | 69 | 0 |
| 31 Mar 18 | 510 | -92 | 59 | 0 |
| 31 Dec 17 | 450 | -76 | 56 | 0 |
| 30 Sep 17 | 416 | -28 | 60 | 0 |
| 30 Jun 17 | 418 | -3 | 65 | 0 |
| 31 Mar 17 | 327 | -36 | 71 | 0 |
| 31 Dec 16 | 593 | 65 | 74 | 0 |
| 30 Sep 16 | 555 | 68 | 73 | 0 |
| 30 Jun 16 | 445 | 17 | 75 | 0 |
| 31 Mar 16 | 458 | 35 | 78 | 0 |
| 31 Dec 15 | 117 | -84 | 75 | 0 |
| 30 Sep 15 | 96 | -107 | 77 | 0 |
| 30 Jun 15 | 171 | -65 | 72 | 0 |
| 31 Mar 15 | 208 | -55 | 71 | 0 |
| 31 Dec 14 | 210 | -80 | 76 | 0 |
| 30 Sep 14 | 247 | -56 | 70 | 0 |
| 30 Jun 14 | 174 | -103 | 76 | 0 |
| 31 Mar 14 | 490 | 102 | 75 | 0 |
| 31 Dec 13 | 505 | 130 | 80 | 0 |
Quality Earnings: 6HL0 is currently unprofitable.
Growing Profit Margin: 6HL0 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6HL0 is unprofitable, but has reduced losses over the past 5 years at a rate of 11.1% per year.
Accelerating Growth: Unable to compare 6HL0's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6HL0 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).
Return on Equity
High ROE: 6HL0 has a negative Return on Equity (-2.18%), as it is currently unprofitable.